STE 7326
No. of Pages 6, Model 5G
20 December 2012
2
A.V. Baranovsky et al. / Steroids xxx (2012) xxx–xxx
80
81
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
1.97 (2H, m, 7-H), 1.99 (1H, m, 15
m, 15b-H), 2.14 (3H, s, 17-AcO), 2.19 (1H, m, 12
4-H), 4.61 (1H, m, 3 -H), 5.38 (1H, dd, J = 3 and 9 Hz, 16b-H), 5.42
a
-H), 2.03 (3H, s, 3-AcO), 2.13 (1H,
2.1.2. 3b-Benzoyloxy-14,17-etheno-16
acetate (8)
a
-nitroandrost-5-en-17b-yl
a-H), 2.35 (2H, m,
82
a
Following the same procedure as for compound 5, compound 2
(0.868 g, 2 mmol) was converted into steroid 8 and its two isomers.
Crystallization of the reaction mixture gave 0.531 g (53%) of nitro
compound 8: m.p. 223–225 °C (benzene). IR (KBr, cmꢀ1): 2940,
1740 (OAc), 1710 (OBz), 1560 and 1370 (NO2), 1275, 1240, 1110.
1H NMR d: 1.02 (3H, s, 18-Me), 1.03 (3H, s, 19-Me), 1.10 (1H, m,
(1H, m, 6-H), 6.19 (1H, J = 6 Hz, 171-H), 6.29 (1H, d, J = 6 Hz,
172-H); 13C NMR d: 14.92 (C-18), 19.37 (C-19), 20.90 (C-11), 21.53
(3-OC(O)CH3), 21.55 (17-OC(O)CH3), 26.41 (C-7), 27.77 (C-2),
28.65 (C-12), 31.46 (C-8), 34.96 (C-15), 36.48 (C-10), 36.84 (C-1),
38.22 (C-4), 46.08 (C-9), 55.44 (C-14), 62.12 (C-13), 73.68 (C-3),
87.34 (C-16), 96.24 (C-17), 121.53 (C-6), 129.72 (C-171), 135.13
(C-172), 139.70 (C-5), 169.74 (17-OC(O)CH3), 170.59 (3-OC(O)CH3).
LRMS m/z (I,%): 444 ([MH]+, 39), 402 ([MHꢀCH2CO]+, 21), 384
([MHꢀAcOH]+, 26), 342 ([MHꢀCH2COꢀAcOH]+, 15), 324
([MHꢀ2AcOH]+, 100), 307 (25), 283 (19). MS2 (444): 402
([MHꢀCH2CO]+, 11), 358 (13), 330 (100), 324 ([MHꢀ2AcOH]+, 20).
MS2 (324): 307 (50), 306 ([MHꢀ2AcOHꢀH2O]+, 100), 296
([MHꢀ2AcOHꢀC2H4]+ 47), 279 (24), 278 ([MHꢀ2AcOHꢀC2H4ꢀH2-
O]+,19), 265 (52), 247 (33). Anal. calcd. for C25H33NO6: C, 67.70;
H, 7.50; N, 3.16. Found. C, 67.38; H, 7.43; N, 3.40. Mother liquor res-
idues were chromatographed on a silica gel column (petroleum
ether: EtOAc = 90: 10) to give three fractions: A – 0.018 g of com-
pound 5; B – 0.163 g of mixture of adducts 5 and 6 (1:1 based on
integration curve in 1H NMR spectrum); C – 0.048 g of mixture of
adducts 6 and 7 (1:1 based on integration curve in 1H NMR
spectrum). Fraction C was repeatedly separated to afford pure 3b-
83
84
85
86
87
88
12b-H), 1.23 (1H, m, 1
H), 1.58 (1H, m, 11 -H), 1.59 (1H, m, 8b-H), 1.73 (1H, m, 2b-H),
1.94 (1H, dt, J = 3 and 13 Hz, 1b-H), 2.01 (2H, m, 7-H), 2.01 (1H,
m, 15 -H), 2.03 (1H, m, 2 -H), 2.15 (1H, m, 15b-H), 2.15 (3H, s,
17-AcO), 2.20 (1H, m, 12 -H), 2.50 (2H, m, 4-H), 4.87 (1H, m, 3
a-H), 1.25 (1H, m, 9a-H), 1.29 (1H, m, 11b-
89
a
90
91
a
a
92
a
a-
93
H), 5.39 (1H, dd, J = 3 and 9 Hz, 16b-H), 5.48 (1H, m, 6-H), 6.20
(1H, J = 6 Hz, 171-H), 6.33 (1H, d, J = 6 Hz, 172-H), 7.44 (2H, m, m-
Ph), 7.55 (1H, m, p-Ph), 8.04 (2H, d, J = 7 Hz, o-Ph); 13C NMR d:
14.95 (C-18), 19.46 (C-19), 20.94 (C-11), 21.58 (17-OC(O)CH3),
26.47 (C-7), 27.90 (C-2), 28.68 (C-12), 31.49 (C-8), 34.99 (C-15),
36.57 (C-10), 36.90 (C-1), 38.33 (C-4), 46.11 (C-9), 55.47 (C-14),
62.15 (C-13), 74.29 (C-3), 87.36 (C-16), 96.27 (C-17), 121.68 (C-6),
128.44 (Ph C-3), 129.69 (Ph C-2), 129.75 (C-171), 130.90 (Ph C-1),
132.93 (Ph C-4), 135.18 (C-172), 139.71 (C-5), 166.11 (3-OC(O)Ph),
169.78(17-OC(O)CH3). LRMS m/z (I,%): 506 ([MH]+, 45), 464
([MHꢀCH2CO]+, 14), 384 ([MHꢀBzOH]+, 24), 342 ([MHꢀBzOHꢀCH2-
CO]+, 25), 324 ([MHꢀBzOHꢀAcOH]+, 100). MS2 (506): 392 (100),
324 ([MHꢀBzOHꢀAcOH]+, 10). MS2 (324): 307 (56), 306
([MHꢀBzOHꢀAcOHꢀH2O]+, 100), 296 ([MHꢀBzOHꢀAcOHꢀC2H4]+
40), 279 (29), 278 ([MHꢀBzOHꢀAcOHꢀC2H4ꢀH2O]+, 17), 265
(52), 247 (15). HRMS calcd for C23H29NO4 (M+ꢀBzOH): 383.2097.
Found. 383.2094. Mother liquor residues were chromatographed
on a silica gel column (petroleum ether: EtOAc = 90: 10) to give
two fractions: A – 0.147 g of compound 8, thus elevating the overall
yield of 8 to 67%; B – 0.191 g of two minor adducts.
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
acetoxy-14,17-etheno-15a-nitroandrost-5-en-17b-yl acetate (6):
m.p.194–196 °C (hexane). IR (KBr, cmꢀ1) 2920, 1740 (OAc) 1730
(OAc), 1550 and 1365 (NO2), 1245, 1030. 1H NMR d: 0.99 (3H, s,
19-Me), 1.02 (3H, s, 18-Me), 1.13 (1H, m, 1
H), 1.18 (1H, m, 12b-H), 1.27 (1H, m, 11b-H), 1.52 (1H, m, 11
1.57 (1H, m, 2b-H), 1.85 (1H, m, 1b-H), 1.87 (1H, m, 2 -H), 1.87
(1H, m, 7 -H), 1.95 (1H, m, 8b-H), 2.01 (1H, m, 7b-H), 2.02 (3H, s,
3-AcO), 2.09 (1H, m, 12 -H), 2.09 (3H, s, 17-AcO), 2.33 (2H, m, 4-
H), 2.49 (1H, dd, J = 9 and 13 Hz, 16b-H), 2.61 (1H, dd, J = 4 and
13 Hz, 16 -H), 4.58 (1H, m, 3 -H), 5.04 (1H, dd, J = 4 and 9 Hz,
a
-H), 1.17 (1H, m, 9
a-
a-H),
a
a
a
a
a
15b-H), 5.31 (1H, m, 6-H), 6.05 (1H, J = 6 Hz, 172-H), 6.58 (1H, d,
J = 6 Hz, 171-H); 13C NMR d: 15.18 (C-18), 19.26 (C-19), 20.57 (C-
11), 21.33 (17-OC(O)CH3), 21.51 (3-OC(O)CH3), 25.71 (C-7), 27.79
(C-2), 28.21 (C-12), 32.7 (C-8), 36.44 (C-10), 37.02 (C-1), 37.99 (C-
4), 39.93 (C-16), 46.23 (C-9), 60.9 (C-14), 62.15 (C-13), 73.61 (C-
3), 89.52 (C-15), 92.54 (C-17), 121.52 (C-6), 129.7 (C-172), 135.49
(C-171), 138.95 (C-5), 170.6 (OC(O)CH3). LRMS m/z (I,%): 444
([MH]+, 43), 384 ([MHꢀAcOH]+, 38), 324 ([MHꢀ2AcOH]+, 100. Anal.
calcd. for C25H33NO6: C, 67.70; H, 7.50; N, 3.16. Found. C, 67.14; H,
7.35; N, 3.26. and 3b-acetoxy-14,17-etheno-15b-nitroandrost-5-
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
2.1.3. 14,17-Etheno-6,6-ethylenedioxy-2
16 -nitro-5 -androstan-17b-yl acetate (9)
A solution of steroid 3 (0.066 g, 0.15 mmol) and nitroethylene
a,3a-isopropylidendioxy-
a
a
(0.54 g, 7.4 mmol) in dry benzene (7 ml) was refluxed for 10 h
and some more nitroethylene (0.27 g, 3.7 mmol) was added.
Refluxing was continued for a further 6 h and the solution was
cooled, evaporated and residue was chromatographed on a silica
gel column (petroleum ether: EtOAc = 90:10) to give steroid 9
(0.038 g, 49%): m.p.132–134 °C (hexane). IR (KBr, cmꢀ1): 2940,
1745 (OAc), 1550 and 1370 (NO2). 1H NMR d: 0.80 (3H, s, 19 Me),
en-17a-yl acetate (7): m.p.205–207 °C. (hexane, dec.). IR (KBr,
cmꢀ1) 2945, 1735 (OAc) 1730 (OAc), 1550 and 1365 (NO2), 1245,
0.98 (3H, s, 18 Me), 1.03 (1H, m, 9
(1H, m, 12b-H), 1.13 (1H, m, 11b-H), 1.34 (3H, s, b-CH3 acetonide),
1.44 (1H, m, 7 -H), 1.48 (3H, s, -CH3 acetonide), 1.58 (1H, m, 11
H), 1.59 (1H, m, 8b-H), 1.70 (1H, m, 7b-H), 1.81 (1H, m, 4b-H), 1.87
(1H, m, 5 -H), 1.93 (1H, m, 1b-H), 1.97 (1H, m, 15 -H), 2.12 (1H,
m, 12 -H), 2.13 (1H, m, 15b-H), 2.15 (3H, s, OAc), 2.23 (1H, d,
J = 15 Hz, 4 -H), 3.80 and 3.94 (2H, m, -CH2 dioxolane), 3.92
a-H), 1.08 (1H, m, 1a-H), 1.08
1040. 1H NMR d: 1.01 (3H, s 18-Me), 1.06 (3H, m, 19-Me), 1.25
(1H, m, 1
m, 2b-H), 1.61 (1H, m, 9
-H), 1.89 (1H, m, 1b-H), 1.90 (1H, m, 2
2.04 (3H, s, 3-AcO), 2.05 (1H, m, 7b-H), 2.10 (3H, s, 17-AcO), 2.35
(2H, m, 4-H), 2.58 (2H, m, 16-H), 4.62 (1H, m, 3 -H), 5.37 (1H, m,
6-H), 5.49 (1H, dd, J = 5 and 8 Hz, 15 -H), 6.10 (1H, d, J = 6 Hz,
a
-H), 1.47 (2H, m, 12-H), 1.54 (1H, m, 11b-H), 1.58 (1H,
-H), 1.69 (1H, m, 11 -H), 1.78 (1H, m,
-H), 1.98 (1H, m, 8b-H),
a
a
a-
a
a
7a
a
a
a
a
a
a
a
a
and 3.99 (2H, m, b-CH2 dioxolane), 4.08 (1H, m, 2b-H), 4.27 (1H,
m, 3b-H), 5.37 (1H, dd, J = 2 and 9 Hz, 16b-H), 6.18 (1H, d, J = 6.4,
171-H), 6.28 (1H, d, J = 6.4, 172-H). 13C NMR d: 13.43 (C-19),
15.04 (C-18), 20.41 (C-11), 21.57 (OC(O)CH3), 22.04 (C-4), 26.70
(b-CH3 acetonide), 28.64 (C-12), 28.77 (
(C-8), 34.82 (C-15), 36.61 (C-7), 38.21 (C-10), 42.69 (C-1), 45.28
(C-5), 48.68 (C-9), 55.18 (C-14), 62.13 (C-13), 64.42 ( -CH2 dioxo-
lane), 65.79 (b-CH2 dioxolane), 72.78 (C-3), 72.84 (C-2), 87.30 (C-
16), 96.02 (C-17), 107.83 (Me2C acetonide), 109.36 (C-6), 129.74
(C-171), 134.61 (C-172), 169.78 (OC(O)CH3). LRMS m/z (I,%): 518
([MH]+, 23), 460 ([MHꢀMe2CO]+, 40), 400 ([MHꢀMe2COꢀAcOH]+,
40), 382 ([MHꢀMe2COꢀAcOHꢀH2O]+, 51), 338 ([MHꢀMe2-
COꢀAcOHꢀH2OꢀCH2CH2O]+, 20). HRMS calcd for C28H39NO8:
517.2676. Found. 517.2679.
172-H), 6.50 (1H, d, J = 6 Hz, 171-H). 13C NMR d: 15.51 (C-18),
19.07 (C-11), 19.53 (C-19), 21.38 (17-OC(O)CH3), 21.52 (3-
OC(O)CH3), 26.94 (C-12), 27.21 (C-7), 27.77 (C-2), 30.49 (C-8),
37.14 (C-1), 37.48 (C-16), 37.58 (C-10), 38.11 (C-4), 43.78 (C-9),
58.88 (C-14), 61.87 (C-13), 73.62 (C-3), 86.33 (C-15), 92.49 (C-17),
122.07 (C-6), 132.05 (C-172), 135.97 (C-171), 139.18 (C-5), 170.56
(3-OC(O)CH3), 170.66 (17-OC(O)CH3). LRMS m/z (I,%): 444 ([MH]+,
100), 384 ([MHꢀAcOH]+, 35), 324 ([MHꢀ2AcOH]+, 68), 306
([MHꢀ2AcOHꢀH2O]+, 13). MS2 (444): 402 ([MHꢀCH2CO]+, 92),
384 ([MHꢀAcOH]+, 100), 324 ([MHꢀ2AcOH]+, 86). Anal. calcd. for
C25H33NO6: C, 67.70; H, 7.50; N, 3.16. Found. C, 66.84; H, 7.40; N,
3.40. Therefore, the overall yield of the adducts was 87% of com-
pound 5, 11% of compound 6 and 2% of compound 7.
a-CH3 acetonide), 32.78
a
Please cite this article in press as: Baranovsky AV et al. Diels–Alder reaction of androsta-14,16-dien-17-yl acetates with nitroethylene: Product distribution